Quick Answer
DarioHealth Corp. reported Diluted EPS of $10.12 per share for fiscal year 2025.
DarioHealth Corp. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $10.12 | -17.5% |
| 2024 | $12.27 | +535.8% |
| 2023 | $1.93 | -24.0% |
| 2022 | $2.54 | -37.6% |
| 2021 | $4.07 | +1.5% |
| 2020 | $4.01 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.96 | -39.7% | +1544.4% |
| June 30, 2025 | $0.18 | +125.0% | +28.6% |
| March 31, 2025 | $0.14 | -30.0% | -97.1% |
| September 30, 2024 | $4.91 | +902.0% | +6037.5% |
| June 30, 2024 | $0.08 | -86.2% | -60.0% |
| March 31, 2024 | $0.20 | -55.6% | -59.2% |
| September 30, 2023 | $0.49 | -23.4% | -15.5% |
| June 30, 2023 | $0.58 | -21.6% | +28.9% |
- DarioHealth Corp. showed a decrease of -17.5% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, DarioHealth Corp.’s diluted eps has grown by 152.4% (from $4.01 per share to $10.12 per share).
- The most recent figure is from DarioHealth Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: